News

In a major boost to efforts to combat COVID-19 globally, a vaccine that recently entered human trials in Vietnam and Thailand, and is slated for a clinical study in Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent on imported vaccines. The vaccine is the result of a partnership between The University of Texas at Austin, the Icahn School of Medicine at Mount Sinai in New York and global partners interested in advancing the supply of affordable vaccines to address the pandemic.

The College of Natural Sciences again invited its faculty, staff and students to submit the best images from their research for our Visualizing Science competition. The images they delivered are the ones that spoke to their creators, offering both inspiration and information as they conducted their scholarly investigations during a challenging year.

Gene editing with CRISPR enzymes inside living cells could become more effective and accurate after researchers at The University of Texas at Austin unveiled how inner workings can help or hinder the process.

The Welch Foundation today announced that Ilya J. Finkelstein, an associate professor of molecular biosciences at The University of Texas at Austin who has been researching the coronavirus and the gene-editing tool CRISPR, will receive the 2021 Norman Hackerman Award in Chemical Research. Having already made significant scientific contributions in chemistry and biochemistry, he is being recognized as a rising star in his field.

​​Four faculty members from the University of Texas at Austin's College of Natural Sciences have received 2021 Sloan Research Fellowships, which honor outstanding early-career scientists in eight fields.

​In search of a way to reduce the amount of plastic pollution an individual creates, a team of undergraduates in the UT Austin Inventors Program are exploring how mealworms, and the microbes in their guts, can naturally degrade household plastics.

The University of Texas at Austin is gearing up to welcome science enthusiasts everywhere to the Texas Science Festival. The virtual celebration features rapid-fire and deep-dive presentations by world-changing scientists, live hands-on demonstrations, explosive science, telescope viewings, opportunities to interact with experts from Texas' flagship public research institution and more.

More effective antiviral treatments could be on the way after research from The University of Texas at Austin sheds new light on the COVID-19 antiviral drug remdesivir, the only treatment of its kind currently approved in the U.S. for the coronavirus.

University of Texas at Austin researchers have been instrumental in tracking the spread of the coronavirus, developing critical antibody treatments to save lives, developing diagnostics and creating the vaccines for SARS-CoV-2 that are currently being distributed around the world.